News | January 25, 2022
Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform
Read More
Press Release | January 19, 2022
Orbus Therapeutics’ Phase 3 Eflornithine STELLAR Study Reaches Full Patient Enrollment
Read More
Press Release | January 6, 2022
Zenas BioPharma Appoints Dr. John Orloff to Board of Directors
Read More
News | December 16, 2021
Verge Genomics Secures $98 Million in New Financing
Read More
